Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LYRA | Common Stock | Purchase | $25M | +5.92M | +306.3% | $4.22 | 7.86M | Apr 12, 2022 | See Footnotes | F1, F3 |
holding | LYRA | Common Stock | 1.29M | Apr 12, 2022 | See Footnotes | F2, F3 |
Id | Content |
---|---|
F1 | The securities reported in this row are held by Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"). |
F2 | The securities reported in this row are held by Perceptive LS (A), LLC ("Perceptive LS"). |
F3 | Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to the Master Fund. Perceptive LS GP, LLC ("GP") is the manager of Perceptive LS. Joseph Edelman is the managing member of the Advisor and the sole member of GP. Each of Mr. Edelman, GP and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman, GP or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. |